Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma

Abstract

SM may have antitumor activity in ASPS, possibly through a mechanism involving PDGFR and RET. The role of MET, epidermal growth factor receptor, and mTOR, as well as PDGFR inhibition, needs to be further explored.